- Exchange: Budapest
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
EGIS Pharmaceuticals PLC
Add to PortfolioEGIS:HB
14,150.00 HUF 150.00 1.07%As of 11:07:00 ET on 05/25/2012.
Snapshot for EGIS Pharmaceuticals PLC (EGIS)
| Open: | 14,000.00 | Day's Range: | 14,000.00 - 14,305.00 | Volume: | 5,933 | Bid: | - |
|---|---|---|---|---|---|---|---|
| Previous Close: | 14,000.00 | 52wk Range: | 13,600.00 - 19,980.00 | 1-Yr Rtn: | -25.91% | Ask: | - |
Stock Chart for EGIS
No chart data available.
- EGIS:HB 14,150.00
- 1D
- 1M
- 1Y
14,000.00
…
Previous Close
Key Statistics for EGIS
| Current P/E Ratio (ttm) | 6.8194 |
|---|---|
| Estimated P/E (09/2012) | 6.1074 |
| Earnings Per Share (HUF) (ttm) | 2,074.9539 |
| Est. EPS (HUF) (09/2012) | 2,316.8580 |
| Est. PEG Ratio | 1.5269 |
| Market Cap (M HUF) | 110,167.87 |
| Shares Outstanding (M) | 7.79 |
| Enterprise Value (M HUF) (ttm) | 83,530.87 |
| Enterprise Value/EBITDA (ttm) | 2.96 |
| Price/Book (mrq) | 0.6370 |
| Price/Sale (ttm) | 0.8517 |
| Dividend Indicated Gross Yield | 0.8481 |
| Next Earnings Announcement | 08/06/2012 |
More EGIS Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for EGIS
- Operating
- Investing
- Financing (M/HUF)
Company Profile & Key Executives for EGIS
Egis Pharmaceuticals PLC develops and manufactures pharmaceuticals and nutritional supplements. The Company produces medicine for the treatment of cardiovascular, central nervous, and respiratory system ailments. Egis distributes its products throughout the world.
| Jean-Philippe SetaChairman-Mgmt Board | Istvan HodaszCEO/Member-Mgmt Board |
| Csaba PoroszlaiCFO/Member-Mgmt Board | Andras DietzDir:Technical/Member-Mgmt Bd |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page